Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Kelly

Showing results (91-100 of 417) with videos related to

Pageof 42
Sort By:
Cancer Research|May 1, 1986
Regulation of DNA synthesis and growth of cells derived from primary human meningiomasA S Weisman, J G Villemure, P A Kelly
Brain Research|December 5, 2000
7-nitroindazole reduces cerebral blood flow following chronic nitric oxide synthase inhibitionP A Kelly, I M Ritchie, D E McBean
Biochemical and Biophysical Research Communications|June 21, 2001
Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cellsF Ammarguellat, M Llovera, P A Kelly, et al.
Journal of the National Cancer Institute|January 1, 1983
N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drugP Gandilhon, R Mélançon, J Djiane, et al.
Biology of Reproduction|December 1, 1980
Stimulatory effect of luteinizing hormone and human chorionic gonadotropin on testicular prolactin receptor levelsP A Kelly, C Séguin, L Cusan, et al.
Neuroscience|June 1, 1988
Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonistsP A Kelly, C J Davis, G M Goodwin
Cancer Research|April 15, 1987
Characterization of the epidermal growth factor receptor in human meningiomaA S Weisman, S S Raguet, P A Kelly
Journal of Consulting and Clinical Psychology|June 1, 1987
Acceptability of behavioral pediatric interventionsK J Tarnowski, P A Kelly, D R Mendlowitz
The Journal of Biological Chemistry|October 6, 1997
Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5A Pezet, F Ferrag, P A Kelly, et al.
Cytokines, Cellular & Molecular Therapy|January 14, 1998
Immune function of prolactin (PRL) and signal transduction by PRL/GH/cytokine receptors: specificity, redundancy and lessons from chimaerasF Ferrag, V Goffin, H Buteau, et al.
Pageof 42

Showing results (91-100 of 417) with videos related to

Sort By:
Pageof 42
Cancer Research|May 1, 1986
Regulation of DNA synthesis and growth of cells derived from primary human meningiomasA S Weisman, J G Villemure, P A Kelly
Brain Research|December 5, 2000
7-nitroindazole reduces cerebral blood flow following chronic nitric oxide synthase inhibitionP A Kelly, I M Ritchie, D E McBean
Biochemical and Biophysical Research Communications|June 21, 2001
Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cellsF Ammarguellat, M Llovera, P A Kelly, et al.
Journal of the National Cancer Institute|January 1, 1983
N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drugP Gandilhon, R Mélançon, J Djiane, et al.
Biology of Reproduction|December 1, 1980
Stimulatory effect of luteinizing hormone and human chorionic gonadotropin on testicular prolactin receptor levelsP A Kelly, C Séguin, L Cusan, et al.
Neuroscience|June 1, 1988
Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonistsP A Kelly, C J Davis, G M Goodwin
Cancer Research|April 15, 1987
Characterization of the epidermal growth factor receptor in human meningiomaA S Weisman, S S Raguet, P A Kelly
Journal of Consulting and Clinical Psychology|June 1, 1987
Acceptability of behavioral pediatric interventionsK J Tarnowski, P A Kelly, D R Mendlowitz
The Journal of Biological Chemistry|October 6, 1997
Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5A Pezet, F Ferrag, P A Kelly, et al.
Cytokines, Cellular & Molecular Therapy|January 14, 1998
Immune function of prolactin (PRL) and signal transduction by PRL/GH/cytokine receptors: specificity, redundancy and lessons from chimaerasF Ferrag, V Goffin, H Buteau, et al.
Pageof 42